Stage II Breast Cancer Active Not Recruiting Phase 1 / 2 Trials for Sargramostim (DB00020)

IndicationStatusPhase
DBCOND0029484 (Stage II Breast Cancer)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01355393Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast CancerTreatment